). Mutations made to residues I96 and A71 greatly decreased mutation of bystander motifs at 9 9 each of the three target sites while retaining 50-75% of A3A N57G BE3 activity at the cognate motif. 1 0 0
These results suggest that it may be possible to further modify eA3A-BE3 using a set of defined 1 0 1 mutations to tune precision at sites with less than optimal cognate-to-bystander editing ratios. 1 0 2
Having characterized the on-target activity of eA3A-BE3, we next sought to characterize and 1 0 3 optimize its potential off-target activity. To do this, we used three different gRNAs (targeted to the 1 0 4 EMX1, FANCF, and VEGFA genes) (Supplementary Table 1) , for which a total of 60 off-targets had 1 0 5 been previously identified with the original BE3 by either Digenome-seq (performed with rAPO1-1 0 6 nSpCas9 also known as "BE3deltaUGI" 16 or GUIDE-seq (performed with SpCas9 nuclease) 1, 17 . Using 1 0 7
GUIDE-seq performed with SpCas9 nuclease, we also identified two potential off-target sites for a a 1 0 8 fourth gRNA (targeted to the CTNNB1 gene) (Supplementary Fig. 5 ). Finally, we identified some 1 0 9 additional closely matched sequences for the CTNNB1-targeting gRNA in silico in the human reference 1 1 0 genome using the Cas-OFFinder program 18 . We then performed targeted amplicon sequencing of these 60 1 1 1 sites to assess base editing events induced by the original BE3 and eA3A-BE3 with the four gRNAs in 1 1 2 human HEK293T cells. For all four gRNAs, on-target base editing efficiency with eA3A-BE3 either 1 1 3 matched or outperformed the original BE3 (Figs. 2a -2d ). For 36 of the 60 potential off-target sites we 1 1 4 examined, BE3 induced significant base editing events (compared to control amplicons from 1 1 5 untransfected cells) (Figs. 2a -2d and Supplementary Table 2) . Surprisingly, at 34 of these 36 off-1 1 6 target sites, eA3A-BE3 induced significantly lower frequencies of base editing events with no significant 1 1 7 detectable editing at 21 of these 36 sites (Figs. 2a -2d) . The N57G mutation in the A3A deaminase part 1 1 8 of eA3A-BE3 is critical for this higher specificity because the A3A-BE3 fusion lacking this alteration 1 1 9
showed higher off-target mutations with the EMX1 site 1 and FANCF site 1 gRNAs (Supplementary 1 2 0 Figure 6 . The addition of mutations previously shown to improve the genome-wide specificity of SpCas9 1 2 1
(the "HF1" and "Hypa" mutations 19, 20 ) together with an additional second UGI domain further reduced 1 2 2 the off-target base editing events (reducing them to undetectable levels for all but 5 of the 15 sites that 1 2 3 still showed detectable edits with eA3A-BE3) (Figs. 2a -2d ). These higher-specificity variants also 1 2 4 induce improved base editing product purity and reduced frequencies of indels at on-target sites 1 2 5 (Supplementary Figure 7) , consistent with earlier studies that used similar strategies to achieve these 1 2 6 outcomes for the original BE3 fusion 10,21 . 1 2 7
To test the eA3A-BE3 fusion on a disease-relevant mutation, we examined its activity on a 1 2 8 common β -thalassemia allele found in China and some Southeast Asian populations 22,23 for which single 1 2 9 nucleotide editing is critical. Mutation of position -28 of the human HBB promoter from an A to G (and 1 3 0 therefore a T to C on the complementary strand) results in β -thalassemia disease (Fig. 3a) . The HBB -28 1 3 1 C mutation can be corrected with SpCas9 and a gRNA with the C falling within the predicted editing 1 3 2 window. However, another C (at position -25 of the HBB promoter) is also present within the editing 1 3 3 window of this gRNA and previous work has shown that mutation of this base can cause a β -thalassemia 1 3 4 phenotype in humans independent of the nucleotide identity at the -28 position (Fig. 3a) 24,25 .We directly 1 3 5 compared the abilities of the original BE3, the YE BE3s, and eA3A-BE3 to edit an integrated copy of 200 1 3 6 bps of mutant HBB promoter sequence encompassing the cytidines at positions -28 and -25 in HEK293T 1 3 7 cells. (For technical reasons, all experiments targeting the HBB -28 (A>G) allele used a gRNA expressed 1 3 8 with a self-cleaving hammerhead ribozyme on its 5' end (Online Methods).) As expected, eA3A-BE3 1 3 9
showed higher precision than BE3 and the YE BE3s for selectively editing the -28 cytidine relative to the 1 4 0 -25 cytidine (Fig. 3b) . This resulted in substantially higher levels of perfectly corrected alleles bearing 1 4 1 only a -28 C to T edit: 22.48% for eA3A-BE3 compared with 0.57%, 1.04%, 0.92%, and 0.76% for BE3, 1 4 2 YE1 BE3, YE2 BE3, and YEE BE3, respectively (Fig. 3c) . Analysis of eight potential off-target sites for and five by in silico methods; Online Methods) showed that eA3A-BE3 induced significant off-target 1 4 5 editing at two sites while BE3 induced significant editing at these same two sites and an additional third 1 4 6 site all at higher frequencies (Fig. 3d) . As expected, use of the eA3A-HF1-BE3-2xUGI and eA3A-Hypa-1 4 7
BE3-2xUGI fusions with the HBB gRNA reduced the frequencies of off-target edits to undetectable levels 1 4 8 at all eight sites we examined (Fig. 3d) . Both high-fidelity base editor fusions also improved product 1 4 9 purity, resulting in a reduction of unwanted -28 C to G edits that are also known to cause β -thalassemia 1 5 0 from 16.3% with eA3A-BE3 to 8.8% and 7.5% with the HF1 and Hypa variants, respectively (Fig. 3c) . 1 5 1
Our study provides an important proof-of-principle for how changing and engineering the 1 5 2 cytidine deaminase in base editors can be used to optimize on-target precision and reduce off-target 1 5 3 effects. We envision that a large suite of base editor fusions can be engineered by exploiting both the rich 1 5 4 diversity of naturally occurring cytidine deaminase domains and the ability to modify the function and 1 5 5 activity of these enzymes using protein engineering and evolution. In our study, mutation of the N57 1 5 6 residue in the human A3A deaminase was critical to restoring its native target sequence precision in the 1 5 7
context of a base editor and also to lowering its off-target base editing activity. Introduction of additional 1 5 8 mutations at A3A residues I96 and A71 further refined this precision, albeit at the expense of the desired 1 5 9 cognate activity. Furthermore, the eA3A deaminase we engineered might be incorporated into and used to 1 6 0 reduce the off-target effects of other base editor architectures that use different Cas9 orthologues for 1 6 1 which high-fidelity variants have not yet been described (e.g., SaCas9 from Staphylococcus aureus 26 ). 1 6 2
Relative to previously published studies, our strategy of using alternative and engineered cytidine 1 6 3 deaminases provides a different and orthogonal approach to improve the precision of on-target editing. 1 6 4
An earlier study introduced mutations into the rAPOBEC1 part of BE3 that shorten the editing window 1 6 5 but this strategy narrows targeting range and does not permit predictable discrimination of base 1 6 6 deamination when multiple cytidines are present in the window (as is the case with the β -thalassemia 1 6 7 HBB -28 promoter mutation we successfully modified with eA3A-BE3 in this study). We also note that 1 6 8 the YE BE3 variants that show the highest discrimination among multiple cytidines also typically show 1 6 9 the greatest reductions in their overall base editing activity. One limitation of eA3A-BE3 is a decreased 1 7 0 targeting range due to the increased sequence requirements flanking the target cytidine, a restriction that 1 7 1 might be addressed by using engineered SpCas9 PAM recognition variants and naturally occurring Cas9 1 7 2 orthologues with different PAM specificities. In this regard, we have constructed an eA3A-BE3 1 7 3 derivative that uses an engineered SpCas9 variant that recognizes an NGA PAM 19 and found that this 1 7 4 fusion can efficiently edit sites bearing this alternative PAM (Supplementary Fig. 8 ). In addition, it may 1 7 5 be possible to engineer or evolve different sequence specificities into APOBEC enzymes in the context of 1 7 6 a base editor architecture, as has been done with APOBEC enzymes in isolation 13, 27 . Thus, in the longer-1 7 7
term, we envision that the targeting range restriction might eventually be completely overcome by 1 7 8 creating a larger series of different base editors that collectively recognize cytidines embedded in any 1 7 9 sequence context. target PCR amplicons for high throughput sequencing in this study can be found in Supplementary 1 8 6 Table 3 . Sequences of oligonucleotides used to investigate off-target editing sites can be found in 1 8 7
Supplementary Table 1. BE expression plasmids containing amino acid substitutions were generated 1 8 8
by PCR and standard molecular cloning methods. gRNA expression plasmids were constructed by 1 8 9
genome.) This class of off-targets is more prevalent in BE3 relative to nucleases 16 , and thus sites that we 2 3 0 were unlikely to discover by GUIDE-seq. Primers were designed to amplify all off-target sites such that 2 3 1 potential edited cytidines were within the first 100 base pairs of Illumina HTS reads. A total of six primer 2 3 2 pairs encompassing EMX1 site 1, VEGFA site 2 and CTNNB1 site 1 off-target sites did not amplify their 2 3 3 intended amplicon and were thus excluded from further analysis.
3 4
Statistical testing 2 3 5
All statistical testing was performed using two-tailed Student's t-test according to the method of 2 3 6
Benjamini, Krieger, and Yekutieli without assuming equal variances between samples. 2 3 7
Targeted amplicon sequencing 2 3 8
On-and off-target sites were amplified from ~100 ng genomic DNA from three biological 2 3 9
replicates for each condition. PCR amplification was performed with Phusion High Fidelity DNA 2 4 0 Polymerase (NEB) using the primers listed in Supplementary Tables 1 and 3 In order to use eA3A BEs with the HF1 or Hypa mutations that decrease genome-wide off-2 5 4 target editing, it was necessary to use 20 nucleotides of spacer sequence in the gRNA with no 2 5 5 mismatches between the spacer and target site 19, 29, 30 . We expressed the HBB -28 (A>G) gRNA from a 2 5 6 plasmid using the U6 promoter, which preferentially initiates transcription at a guanine nucleotide at 2 5 7 the +1 position. To preserve perfect matching between the spacer and target site, we appended a self-2 5 8
cleaving 5' hammerhead ribozyme that is able to remove the mismatched guanine at the 5' of the 2 5 9 spacer 30 . This strategy rescued activity of HF1 eA3A BE3.9 or Hypa eA3A BE3.9 by approximately 2 6 0 1.4-fold compared to the gRNA with a 5' mismatched guanine (Supplementary Fig. 9 ). 2 6 1 Data Availability 2 6 2 High-throughput sequencing reads will be deposited in the NCBI Sequence Read Archive database 2 6 3 prior to publication. 2 6 4 2 6 5
